Is Schizophrenia Preventable? |
| News - Psychopathology | ||
| Written by Keiron Walsh | ||
| Friday, 29 January 2010 08:13 | ||
|
It may be possible to prevent people with a genetic risk of schizophrenia from developing the disorder, according to Professor Ina Weiner from Tel Aviv University. Schizophrenia is a mental illness characterised by hallucinations, delusions and negative symptoms, such as anhedonia, loss of emotion and social withdrawal. There may be as many as 14 genes involved in schizophrenia; however, there are also environmental risk factors, such as exposure to cytokines in the womb. It is thought that these cytokines are produced by the mother's immune system in response to a viral infection, such as flu. Although schizophrenia may be triggered in the womb, the disorder does not develop until early adulthood. Schizophrenia is usually treated with antipsychotic medication; however these medications are not always effective and they often have very unpleasant side effects. "Pharmacological treatments for schizophrenia remain unsatisfactory, so clinicians and researchers like myself have started to dig in another direction," says Prof. Weiner. "The big question asked in recent years is if schizophrenia can be prevented."
"We wondered if we could use neuro-imaging to track any early-onset changes in the brains of laboratory animals," Prof. Weiner says. "If so, could these changes and their accompanying schizophrenia-like symptoms be prevented if caught early enough?" Prof. Weiner and her team gave pregnant rats a viral mimic known to induce a schizophrenia-like behavioral disorder in the offspring. This method simulates maternal infection in pregnancy, a well known risk factor for schizophrenia. Prof. Weiner demonstrated that the rat offspring were normal at birth and during adolescence. But in early adulthood, the animals, like their human counterparts, began to show schizophrenia-like symptoms. Looking at brain scans and behavior, Prof. Weiner found abnormally developing lateral ventricles and the hippocampus in those rats with "schizophrenia." Those that were at high risk for the condition could be given drugs to treat their brains, she determined. Following treatment with risperidone and clozapine, two commonly used drugs to treat schizophrenia, brain scans showed that the lateral ventricles and the hippocampus retained a healthy size. "Clinicians have suspected that these drugs can be used to prevent the onset of schizophrenia, but this is the first demonstration that such a treatment can arrest the development of brain deterioration," says Prof. Weiner. She says that the drugs work best when delivered during the rats' "adolescent" period, several months before they reached full maturity. Now, anti-psychotics are prescribed only when symptoms are present. Prof. Weiner believes that an effective non-invasive prediction method (looking at the developmental trajectory of specific changes in the brain), coupled with a low dose drug taken during adolescence, could stave off schizophrenia in those most at risk. More research is needed to see at what point changes in the brain can be detected, work that Prof. Weiner has already begun. She adds that the neuroimaging was performed in the Alfredo Federico Strauss Center for Computational Neuro-Imaging, Raymond and Beverly Sackler Center for Biophysics, Tel Aviv University.
Source: Adapted from materials provided by EurekAlert (Press Release) |
||
| Last Updated ( Friday, 29 January 2010 09:11 ) |










